About us Contacts Interactions: 12170
Drug search by name

Jakafi and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Result of checking the interaction of Jakafi and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) for safety when used together.

Check result:
Jakafi <> High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Relevance: 03.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug interaction with food or lifestyle.

Consumer:

The use of ruxolitinib may increase total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides. It is recommended to assess lipid parameters approximately 8-12 weeks following initiation of therapy and to monitor and treat per clinical guidelines for the management of hyperlipidemia. Care should be exercised when using this agent in patients with lipids disorders.

Professional:

The use of ruxolitinib may increase total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides. It is recommended to assess lipid parameters approximately 8-12 weeks following initiation of therapy and to monitor and treat per clinical guidelines for the management of hyperlipidemia. Care should be exercised when using this agent in patients with lipids disorders.

Jakafi

Generic Name: ruxolitinib

Brand Name: Jakafi

Synonyms: n.a.

What is Jakafi?
Another drug Delete
The list of popular interactions
CookedMed World
Disease interaction
  1. Jakafi
Drug interactions
  1. Jakafi
We use cookies to improve the site's performance. By continuing, you agree to use the cookies. OK